population health

News
Practice Patterns, Predictors of Survival for Older Patients With MCL
05/27/2020
A new study assessed clinical outcomes and predictors of survival in older patients with mantle cell lymphoma (MCL) treated in the rituximab era. Results of the study are to be presented at the American Society of...
A new study assessed clinical outcomes and predictors of survival in older patients with mantle cell lymphoma (MCL) treated in the rituximab era. Results of the study are to be presented at the American Society of...
A new...
05/27/2020
Journal of Clinical Pathways
Perspectives
Rationale for the Development of Clinical Pathways and an Overview of the Clinical Pathways Office at the Seattle Cancer Care Alliance
09/19/2017
Abstract: The United States health care system continues moving away from an unsustainable fee-for-service payment model to more novel measures of care delivery. Clinical pathways have emerged as one of the...
Abstract: The United States health care system continues moving away from an unsustainable fee-for-service payment model to more novel measures of care delivery. Clinical pathways have emerged as one of the...
...
09/19/2017
Journal of Clinical Pathways
Research in Review
Patient Values, Concerns Influence Breast Cancer Treatment Decisions
08/17/2017
JCP Editors
Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...
Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...
...
08/17/2017
Journal of Clinical Pathways
Feature
Multidisciplinary Management of Multiple Myeloma in Older Adults
08/17/2017
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
...
08/17/2017
Journal of Clinical Pathways
Research in Review
Pediatric APL Outcomes Improved By Arsenic Trioxide Consolidation
08/03/2017
JCP Editors
Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia (APL), according to a...
Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia (APL), according to a...
...
08/03/2017
Journal of Clinical Pathways
Research in Review
Older Patients With Advanced-Stage Rectal Cancer Often Receive Sub-Optimal Treatment
08/01/2017
JCP Editors
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...
A...
08/01/2017
Journal of Clinical Pathways
Research in Review
Clinical Trial Efficacy Consistent with Real-World Outcomes, Study Shows
07/28/2017
JCP Editors
Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies, published in Value in Health (July-August,...
Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies, published in Value in Health (July-August,...
...
07/28/2017
Journal of Clinical Pathways
Research in Review
ADT Plus Combination Therapy Improves Outcomes in Metastatic Prostate Cancer
07/28/2017
JCP Editors
A combination regimen plus androgen-deprivation therapy prolongs overall survival (OS) and radiographic progression-free survival (PFS) in newly diagnosed patients with metastatic, castration-sensitive prostate...
A combination regimen plus androgen-deprivation therapy prolongs overall survival (OS) and radiographic progression-free survival (PFS) in newly diagnosed patients with metastatic, castration-sensitive prostate...
A...
07/28/2017
Journal of Clinical Pathways
Research in Review
High-Priority Areas for Quality Improvement Identified for Breast Cancer Treatment
07/26/2017
JCP Editors
Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy. ----- Related...
Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy. ----- Related...
...
07/26/2017
Journal of Clinical Pathways
Research in Review
Predictor of Aggressive Disease in Multiple Myeloma Identified
07/18/2017
JCP Editors
Certain patients with multiple myeloma often have poorer outcomes, according to a recent meta-analysis. ----- Related Content Circulating tumor cells may help guide bladder cancer treatment Plasma ghrelin levels...
Certain patients with multiple myeloma often have poorer outcomes, according to a recent meta-analysis. ----- Related Content Circulating tumor cells may help guide bladder cancer treatment Plasma ghrelin levels...
...
07/18/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use